Press release
Global Xeljanz Tofacitnib Drug Market, Size, Share, Analysis Report & Forecast to 2026
The global xeljanz tofacitnib market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor for the growth of the market is the increase in the number of arthritis patients which include patients suffering from rheumatoid arthritis, psoriatic arthritis, and ulcerative arthritis. According to the Global RA Network, around 350 million people across the globe are suffering from arthritis. Arthritis caused the US healthcare system to spend around $303 billion each year, according to the data submitted by the Centers for Disease Control and Prevention (CDC). This, in turn, is driving the demand for xeljanz tofacitnib drugs for the treatment of arthritis patients.
Free Sample Copy @ https://www.omrglobal.com/request-sample/xeljanz-tofacitnib-drug-market
The drug is marketed under the name of Xeljanz by Pfizer; it is a Janus kinases drug. The drug targets the reduction of inflammation caused by rheumatoid arthritis, by inhibiting the janus kinases which is involved in the inflammatory response pathway. In August 2021, the European Commission (EC) had approved the drug for the treatment of arthritis in Europe, which will further increase the demand for these drugs.
A Full Report of Global Xeljanz Tofacitnib Drug Market is Available at:
https://www.omrglobal.com/industry-reports/xeljanz-tofacitnib-drug-market
In addition to this, the EC has also approved the prolonged-release 11 mg version of the drug for the treatment of patients suffering from JPsA (juvenile psoriatic arthritis). In August 2021, Zydus Cadila, which is a part of Cadila Healthcare, received the final approval for the 180- days exclusivity for Xeljianz generic in the US.
Global Xeljanz Tofacitnib Drug Market – Segmentation
By Type
Tablets
Extended-Release Tablets
By Application
Rheumatoid Arthritis
Psoriatic Arthritis
Other
Global Xeljanz Tofacitnib Drug Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Novartis Inc.
Eli Lilly
Pfizer Inc.
AbbVie
Zydus Cadila
Teva Pharmaceuticals
Cipla
Natco Pharma
Intas Biopharmaceuticals
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/xeljanz-tofacitnib-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Free Sample Copy @ https://www.omrglobal.com/request-sample/xeljanz-tofacitnib-drug-market
The drug is marketed under the name of Xeljanz by Pfizer; it is a Janus kinases drug. The drug targets the reduction of inflammation caused by rheumatoid arthritis, by inhibiting the janus kinases which is involved in the inflammatory response pathway. In August 2021, the European Commission (EC) had approved the drug for the treatment of arthritis in Europe, which will further increase the demand for these drugs.
A Full Report of Global Xeljanz Tofacitnib Drug Market is Available at:
https://www.omrglobal.com/industry-reports/xeljanz-tofacitnib-drug-market
In addition to this, the EC has also approved the prolonged-release 11 mg version of the drug for the treatment of patients suffering from JPsA (juvenile psoriatic arthritis). In August 2021, Zydus Cadila, which is a part of Cadila Healthcare, received the final approval for the 180- days exclusivity for Xeljianz generic in the US.
Global Xeljanz Tofacitnib Drug Market – Segmentation
By Type
Tablets
Extended-Release Tablets
By Application
Rheumatoid Arthritis
Psoriatic Arthritis
Other
Global Xeljanz Tofacitnib Drug Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Novartis Inc.
Eli Lilly
Pfizer Inc.
AbbVie
Zydus Cadila
Teva Pharmaceuticals
Cipla
Natco Pharma
Intas Biopharmaceuticals
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/xeljanz-tofacitnib-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
